NCT06472076
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06472076
Title A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors GlaxoSmithKline
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | SWE | NLD | FRA | FIN | ESP | DEU | CAN | BRA | BGR | BEL | ARG

Facility Status City State Zip Country Details
GSK Investigational Site Ocala Florida 34474 United States Details
GSK Investigational Site Honolulu Hawaii 96819 United States Details
GSK Investigational Site Lexington Kentucky 40503 United States Details
GSK Investigational Site Lexington Kentucky 40509 United States Details
GSK Investigational Site Ann Arbor Michigan 48106 United States Details
GSK Investigational Site Omaha Nebraska 68114 United States Details
GSK Investigational Site Nashville Tennessee 37203 United States Details
GSK Investigational Site Fort Worth Texas 76104 United States Details
GSK Investigational Site Olympia Washington 98506 United States Details
GSK Investigational Site Buenos Aires 1425 Argentina Details
GSK Investigational Site Cipoletti Rio Negro R8324CVE Argentina Details
GSK Investigational Site Ciudad Autonoma de Buenos Aire C1426AGE Argentina Details
GSK Investigational Site Ciudad Autonoma de Bueno C1056ABI Argentina Details
GSK Investigational Site Córdoba 5000 Argentina Details
GSK Investigational Site Florida 1602 Argentina Details
GSK Investigational Site Mendoza M5500AYB Argentina Details
GSK Investigational Site Rosario S2002KDT Argentina Details
GSK Investigational Site Rosario S2002 Argentina Details
GSK Investigational Site San Miguel de Tucumán T4000 Argentina Details
GSK Investigational Site Hasselt 3500 Belgium Details
GSK Investigational Site Mont Gaston 5530 Belgium Details
GSK Investigational Site Barretos 14784-400 Brazil Details
GSK Investigational Site Belém 66.073-005 Brazil Details
GSK Investigational Site CuritibaPR 80810-050 Brazil Details
GSK Investigational Site Florianópolis 88034-000 Brazil Details
GSK Investigational Site Fortaleza 60336-232 Brazil Details
GSK Investigational Site Londrina 86015-520 Brazil Details
GSK Investigational Site Porto VelhoRondOnia 76.834-899 Brazil Details
GSK Investigational Site Salvador 40414-120 Brazil Details
GSK Investigational Site SAo JosE Do Rio PretoSP 15090-000 Brazil Details
GSK Investigational Site São Paulo 04312903 Brazil Details
GSK Investigational Site Vitória 29043-260 Brazil Details
GSK Investigational Site Haskovo 6300 Bulgaria Details
GSK Investigational Site Plovdiv 4004 Bulgaria Details
GSK Investigational Site Halifax Nova Scotia B3H 1V7 Canada Details
GSK Investigational Site Chengdu 610000 China Details
GSK Investigational Site Hangzhou 310006 China Details
GSK Investigational Site Hangzhou China Details
GSK Investigational Site Hefei 230001 China Details
GSK Investigational Site Nanjing 210006 China Details
GSK Investigational Site Shanghai 200030 China Details
GSK Investigational Site Kuopio 70210 Finland Details
GSK Investigational Site Turku 20520 Finland Details
GSK Investigational Site Angers 49000 France Details
GSK Investigational Site Boulogne-Billancourt 92100 France Details
GSK Investigational Site Limoges 87042 France Details
GSK Investigational Site Lorient 56100 France Details
GSK Investigational Site Pessac 33064 France Details
GSK Investigational Site Rennes 35033 France Details
GSK Investigational Site Hamburg 20251 Germany Details
GSK Investigational Site Shatin Hong Kong Details
GSK Investigational Site Gokul Shirgoan Kolhapur 416234 India Details
GSK Investigational Site Ahmedabad-380016 380 016 India Details
GSK Investigational Site Apex Wellness Hospital 422005 India Details
GSK Investigational Site Bangalore 560066 India Details
GSK Investigational Site Bangalore 560085 India Details
GSK Investigational Site Belagavi 590010 India Details
GSK Investigational Site Bhubaneshwar 751007 India Details
GSK Investigational Site Bhubaneswar 751019 India Details
GSK Investigational Site Gurgaon 122001 India Details
GSK Investigational Site Kolkata 700020 India Details
GSK Investigational Site New Delhi 110075 India Details
GSK Investigational Site Aichi 466-8560 Japan Details
GSK Investigational Site Chiba 273-8588 Japan Details
GSK Investigational Site Ehime 790-0024 Japan Details
GSK Investigational Site Ehime 791-0280 Japan Details
GSK Investigational Site Fukuoka 812-8582 Japan Details
GSK Investigational Site Fukuoka 814-0180 Japan Details
GSK Investigational Site Gifu 503-8502 Japan Details
GSK Investigational Site Gunma 377-0280 Japan Details
GSK Investigational Site Hiroshima 737-0023 Japan Details
GSK Investigational Site Hokkaido 062-0931 Japan Details
GSK Investigational Site Hyōgo 665-0827 Japan Details
GSK Investigational Site Hyōgo 670-8520 Japan Details
GSK Investigational Site Kanagawa 236-0051 Japan Details
GSK Investigational Site Kyoto 612-8555 Japan Details
GSK Investigational Site Mie 515-8544 Japan Details
GSK Investigational Site Miyagi 981-0914 Japan Details
GSK Investigational Site Miyagi 981-1293 Japan Details
GSK Investigational Site Nagasaki 852-8501 Japan Details
GSK Investigational Site Niigata 951-8566 Japan Details
GSK Investigational Site Okayama 710-8602 Japan Details
GSK Investigational Site Osaka 591-8555 Japan Details
GSK Investigational Site Osaka 596-8501 Japan Details
GSK Investigational Site Tochigi 329-0498 Japan Details
GSK Investigational Site Tokyo 104-0045 Japan Details
GSK Investigational Site Tokyo 113-8603 Japan Details
GSK Investigational Site Tokyo 162-8655 Japan Details
GSK Investigational Site Tottori 683-8504 Japan Details
GSK Investigational Site Wakayama 641-8510 Japan Details
GSK Investigational Site Guadajalara 44280 Mexico Details
GSK Investigational Site La Paz BCS 23040 Mexico Details
GSK Investigational Site Mexico City 06700 Mexico Details
GSK Investigational Site San Luis Potosí City 78209 Mexico Details
GSK Investigational Site Alkmaar 1815 JD Netherlands Details
GSK Investigational Site Enschede 7512 KZ Netherlands Details
GSK Investigational Site Panama City Panama Details
GSK Investigational Site Punta Pacifica Panama City Panama Panama Details
GSK Investigational Site Daegu 41404 South Korea Details
GSK Investigational Site Incheon 21565 South Korea Details
GSK Investigational Site Seoul 02841 South Korea Details
GSK Investigational Site Seoul 03312 South Korea Details
GSK Investigational Site Seoul 05505 South Korea Details
GSK Investigational Site Seoul 08308 South Korea Details
GSK Investigational Site Seoul 120-752 South Korea Details
GSK Investigational Site A Coruña 15006 Spain Details
GSK Investigational Site Aravaca 28013 Spain Details
GSK Investigational Site BaracaldoVizcaya 48903 Spain Details
GSK Investigational Site Barcelona 08003 Spain Details
GSK Investigational Site Barcelona 08023 Spain Details
GSK Investigational Site Barcelona 08025 Spain Details
GSK Investigational Site Barcelona 08035 Spain Details
GSK Investigational Site Cartagena Murcia 30202 Spain Details
GSK Investigational Site Córdoba 14004 Spain Details
GSK Investigational Site Jaén 23007 Spain Details
GSK Investigational Site Las Palmas de Gran Canar 35016 Spain Details
GSK Investigational Site Madrid 28007 Spain Details
GSK Investigational Site Madrid 28010 Spain Details
GSK Investigational Site Madrid 28033 Spain Details
GSK Investigational Site Madrid 28222 Spain Details
GSK Investigational Site Málaga 29016 Spain Details
GSK Investigational Site Oviedo 33006 Spain Details
GSK Investigational Site Pamplona 31008 Spain Details
GSK Investigational Site Salamanca 37007 Spain Details
GSK Investigational Site Santander 39008 Spain Details
GSK Investigational Site Seville 41014 Spain Details
GSK Investigational Site Valladolid 47003 Spain Details
GSK Investigational Site Gävle SE-801 87 Sweden Details
GSK Investigational Site Kaohsiung City 807 Taiwan Details
GSK Investigational Site Taipei 23561 Taiwan Details
GSK Investigational Site Adana 1120 Turkey (Türkiye) Details
GSK Investigational Site Ankara 06560 Turkey (Türkiye) Details
GSK Investigational Site Ankara 06800 Turkey (Türkiye) Details
GSK Investigational Site Istanbul 34722 Turkey (Türkiye) Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field